11. Co-Morbidity and IBD
Understanding of the effects of concurrent medical conditions on the treatment of IBD
Full content only available after log-in
11.1. Knows the importance of assessing co-morbidities in patients with IBD
11.2. Knows the risks relating to a previous history of malignancy or the development of malignancy in IBD, in particular how this affects treatment options.
11.3. Knows the risks relating to infections such as tuberculosis, hepatitis B, hepatitis C and HIV in relation to the treatment of IBD
11.4. Knows the circumstances in which patients should be screened for or immunised against infectious diseases before commencing therapy
11.5. Is aware of the appropriate investigations and vaccination strategy for patients with a new diagnosis of IBD